Guide to Degenerative Myelopathy Testing in Dogs: What U.S. Owners Should Know

Degenerative myelopathy (DM) is a progressive neurological disorder that slowly undermines coordination and muscle strength, initially targeting a dog’s hind legs and potentially leading to paralysis. This inherited disease stems from mutations in the SOD1 gene and impacts numerous pedigree dog breeds in the U.S., with symptoms and severity that differ widely among them. Understanding and utilizing genetic testing is an essential tool for veterinarians, breeders, and dog guardians aiming to minimize DM's impact on future canine generations.

What Is Canine Degenerative Myelopathy?

DM primarily damages the spinal cord, causing a gradual loss of motor function and coordination in the rear limbs. Early signs often include dragging or scuffing one or both back paws and noticeable weakness. As the disease advances over months or even years, paralysis can extend to the front limbs, affect cranial nerves, and impair respiratory muscles. Because there is no cure, humane euthanasia is sometimes the most compassionate option when a dog’s quality of life deteriorates significantly.

This condition typically emerges in dogs around 7 or 8 years of age or older, which can delay diagnosis since affected dogs may have already been bred. The progression rate varies; while some dogs may develop paralysis within a single year of symptom appearance, others experience a more gradual decline.

Breeds Especially Vulnerable to DM in the U.S.

Although mutations of the SOD1 gene occur across many breeds, a handful exhibit notably higher risk. Among the breeds of particular concern in the U.S. are French Bulldog puppies, German Shepherd puppies, Pembroke Welsh Corgi puppies, and Boxer puppies. Responsible U.S. breeders routinely screen for DM to help prevent affected dogs from passing on the mutation. Other breeds like the Chesapeake Bay Retriever and the Bernese Mountain Dog are also monitored closely in American breeding programs.

Understanding the Inheritance of Degenerative Myelopathy

DM follows an autosomal recessive inheritance pattern, meaning a dog must inherit two copies of the mutated SOD1 gene—one from each parent—to be at significant risk of developing the disease. Dogs possessing only one mutated copy are carriers; they don’t usually display symptoms but can transmit the gene to their puppies.

Breeding two dogs clear of the mutation results in litters free from DM genes. Conversely, breeding two affected dogs guarantees all puppies inheriting the disease risk. Matings involving carriers create mixed offspring, making genetic testing essential to navigate breeding choices and reduce DM cases responsibly.

How to Have Your Dog Tested for Degenerative Myelopathy

Genetic testing for DM is crucial for breeders and owners of at-risk breeds in the U.S., particularly since symptoms usually develop later in life and affected dogs might look healthy initially.

Step 1: Talk With Your Veterinarian

Ask your American veterinarian to perform a DM genetic test. They can obtain DNA via a simple blood draw or cheek (buccal) swab, both minimally invasive procedures.

Step 2: Laboratory Analysis

Your vet will send the sample to a certified genetic testing laboratory in the U.S., such as the University of Missouri's Animal Molecular Genetics Lab. Results typically arrive within 7 to 10 business days. Testing costs generally range from $70 to $100 depending on the lab and location.

Step 3: Decoding the Results

Your dog will be classified as Clear (no DM gene mutation), Carrier (one mutated SOD1 gene), or At-Risk (two mutated genes). This information informs breeding decisions and assists owners in anticipating possible health issues. For comprehensive details on labs offering these tests, check resources like the Orthopedic Foundation for Animals (OFA).

Why Ethical Breeding Is Vital

U.S. breeders who ensure they only breed dogs tested clear of DM or who avoid breeding affected dogs contribute to decreasing the burden of this disease. Commitments to responsible breeding protect future generations, enhance canine welfare, and uphold high ethical standards within the breeding community.

Wrap-Up and Recommendations

Testing for degenerative myelopathy is an invaluable resource for safeguarding the health of dogs, especially breeds more susceptible to the condition. Early screening combined with veterinary evaluation empowers breeders and owners to make informed choices that help reduce the incidence of this debilitating illness.

If you’re planning to bring home a new puppy, be sure to look for reputable breeders and discuss health screenings upfront. A proactive approach gives your new canine companion the healthiest start possible.

Armed with knowledge, American dog owners and breeders can work together to foster responsible practices, enhance dogs’ quality of life, and limit hereditary disease risks like degenerative myelopathy.